ArticleProstate international2019

Sarcopenia is a poor prognostic factor of castration-resistant prostate cancer treated with docetaxel therapy.

Ayako Ohtaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.